secwatch.observer — SEC 8-K summary
======================================

Issuer:     TENAX THERAPEUTICS, INC. (TENX)
CIK:        0000034956
Form:       8-K
Filed at:   2026-01-09T23:59:59+00:00
Accession:  0001654954-26-000232
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tenax CMO Dr. Stuart Rich moves to 4-day work week; salary prorated 80%
-----------------------------------------------------------------------

- Effective Jan 1, 2026, Dr. Rich will average 4 days per week as CMO.
- Annual base salary prorated to 80% (80% of prior salary) reflecting reduced schedule.
- Board approved amendment on Dec 22, 2025; executed Jan 6, 2026.
- Executive acknowledges voluntary consent and no 'Good Reason' for termination.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/34956/000165495426000232/0001654954-26-000232-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/34956/000165495426000232/tennx_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-26-000232

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer